Invesco Biotechnology & Genome ETF (NY:PBE)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
1.3% below 52-week high
98.72
72.2752W Low
99.9952W High
1 Week
1.3% below 1-week high
96.501W Low
99.991W High
Invesco Biotechnology & Genome ETF (PBE) traded between $72.27 and $99.99 over the past 52 weeks and last traded at $98.72, 1.3% below its 52-week high. Over the past week it ranged between $96.50 and $99.99.
Past 12 Months
+2.1%
+2.5%
+10.2%
+23.7%
+19.9%
+34.8%
1W
+$2.01
1M
+$2.45
3M
+$9.12
6M
+$18.90
YTD
+$16.37
1Y
+$25.51
PBE was +34.8% over the past year, +23.7% over six months, +19.9% year to date, +2.1% in the last week.
12 Months vs Market
PBE
DIA
SPY
QQQ
IWM
Over the past 12 months PBE returned +34.8% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
0.27× 3-mo avg
Today 7,710
3-mo avg 29.0K
1W
1M
3M
6M
YTD
1Y
PBE most recently traded 7,710 shares against a 3-month average daily volume of 29.0K. More NewsRead More
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗
September 15, 2026
Via The Motley Fool
Topics
ETFs
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? ↗
September 09, 2026
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗
August 21, 2026
Via The Motley Fool
Topics
ETFs
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
August 12, 2026
Via The Motley Fool
Topics
ETFs
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? ↗
August 01, 2026
Via The Motley Fool
Topics
ETFs
VHT vs. PBE: Which Health Care ETF Is the Better Buy? ↗
July 30, 2026
Via The Motley Fool
Topics
ETFs
Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
January 26, 2026
Via Stocktwits
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
February 19, 2024
Via InvestorPlace
US Judge Weighs Nationwide Ban On Abortion Pills ↗
March 16, 2023
Via Benzinga
7 Best Biotech Stocks to Buy in July 2022 ↗
July 08, 2022
Via InvestorPlace
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
Via Talk Markets
A Comprehensive Guide To Genomic ETFs ↗
July 11, 2021
Via Talk Markets
Frequently Asked QuestionsIs Invesco Biotechnology & Genome ETF publicly traded?
Yes, Invesco Biotechnology & Genome ETF is publicly traded.
What exchange does Invesco Biotechnology & Genome ETF trade on?
Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Biotechnology & Genome ETF?
The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
What is the current price of Invesco Biotechnology & Genome ETF?
The current price of Invesco Biotechnology & Genome ETF is 98.72
When was Invesco Biotechnology & Genome ETF last traded?
The last trade of Invesco Biotechnology & Genome ETF was at 10/23/26 08:00 PM ET
What is the market capitalization of Invesco Biotechnology & Genome ETF?
The market capitalization of Invesco Biotechnology & Genome ETF is 3.41M
How many shares of Invesco Biotechnology & Genome ETF are outstanding?
Invesco Biotechnology & Genome ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>